15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. - Wikidata - awgldk - TriplyDB

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

http://www.wikidata.org/entity/Q40248466

about

Regulation of inflammation in cancer by eicosanoids Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂ Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy Association of 15-hydroxyprostaglandin dehydrogenate and poor prognosis of obese breast cancer patients.Loss of 15-hydroxyprostaglandin dehydrogenase expression contributes to bladder cancer progression miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.Restoration of leukotriene B(4)-12-hydroxydehydrogenase/15- oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo.Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma.A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.Eicosanoids and cancer Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.Expression of 15-hydroxyprostaglandin dehydrogenase and cyclooxygenase-2 in non-small cell lung cancer: Correlations with angiogenesis and prognosis 15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways.The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃ Transcriptomic and proteomic analyses of resistant host responses in Arachis diogoi challenged with late leaf spot pathogen, Phaeoisariopsis personata Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm.15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma Increased Growth of a Newly Established Mouse Epithelial Cell Line Transformed with HPV-16 E7 in Diabetic Mice.The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.MicroRNA and AU-rich element regulation of prostaglandin synthesis The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries COX inhibitors directly alter gene expression: role in cancer prevention?Inflammation and lung carcinogenesis: applying findings in prevention and treatment.15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomas Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer

P2860

Q24564308-FA7334B8-F1A1-4124-94AD-314FE98A4911 Q26742070-4EC98DCE-C2D1-49B2-8A72-55B7305A74EC Q26828414-86399580-5D0D-4B88-950B-ABE3E8F7DF20 Q27008521-D190CFC7-2299-4C12-A7A0-7A5F7695DD7A Q28073195-94EED3E4-4E13-4A24-BDC3-2B8FAC00D350 Q28218639-DCE81DBD-1657-4380-9EA6-079555D87F70 Q33313240-E9441ED4-EDEE-4465-9663-50BA19D97295 Q33458922-3D8260E9-25B5-42C3-88BB-5A3A20625EA5 Q33555154-80791CF2-3BC7-4062-B917-DB7646D2075E Q33577548-8C9010AA-41BF-4718-8328-716FDF6FA51F Q33618485-FC41A274-79C7-4CCA-9885-600963F6F5BA Q33703804-318C705F-5053-418D-9E49-2CD2B4717235 Q33758343-99FC78B0-F452-4776-B943-92150FDB0B4B Q33759512-F9A80CEC-0EE7-4F86-A352-D910F3511A1A Q33773701-AD0F6A7F-8A9C-41E9-9778-EBB17242BE80 Q33798719-45EC85DB-4CEB-494B-B020-748D4CA85A46 Q33864360-FECAE062-7880-4532-862F-C11E997A912F Q33872540-FB93528E-15A7-43C9-9563-A4A4F30DD878 Q33966203-E69299B0-8192-4978-92F0-C42BBC6B891F Q34015084-AD089441-B84B-4AF8-AAA6-5FCA1A0C802A Q34141517-ED242E33-E3E2-4621-828F-FF689194B6AB Q34450882-7B1FFEE2-20AD-4F94-9362-C28C0450F25B Q35188826-D408CB25-2B76-4BA3-9B6E-3BC022E9C10A Q35554177-68FC8103-203C-4746-9CDC-1F3329A1704A Q35749972-BE4EF2F7-9C14-4CD8-8088-1CA6694AA574 Q35813184-251636CB-E55C-4162-A309-909C90604AD0 Q35968264-D9E7655C-44C7-490F-8CBE-5BBE5B7BF40A Q36113576-77D03F6A-6843-460B-9149-1C5244404953 Q36165287-04D7005D-33E9-4DEA-AC22-001C2554240B Q36195219-443DE827-018C-424B-BC10-048EF02A29D3 Q36249379-63C8F4A7-3FDE-409D-8094-02CC02BD62AC Q36339264-D4AE4E49-BA4F-47AA-87E3-D6BF7A549AC1 Q36355984-FEBBF90F-DDF7-4251-84BC-51924147F2E1 Q36498640-B916A457-CA29-4A5D-B13D-0C314E62660B Q36635956-75D6EC13-7FED-469A-A2D1-57EC894343EF Q36974700-3585BCBE-39AC-4489-BA5B-40AACFDA7B2B Q37000533-95C3EE18-FDE1-449A-A694-C66E5EEC06D8 Q37065177-6AD17092-3791-4A2A-88E1-8F9E2F3A59EC Q37067304-4A02CE3C-AD74-48C2-B382-E9F342003A4D Q37148157-3A0C2157-A070-444D-8909-88E8EB12765B

P2860

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

http://www.wikidata.org/entity/Q40248466

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

@en

type

label

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

@en

prefLabel

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

@en

P1433

Q40248466-AB403CE7-02DB-4550-A28C-61590DBB8751

P1476

Q40248466-96686FAB-401D-49E1-BD77-BD078D1653E1

P2093

Q40248466-214AF3C0-EE3E-43FA-82A3-AABFBD23E521

Q40248466-33D6BAAD-285F-4DCC-A659-968FC8D2003D

Q40248466-54926530-A7F1-47DA-BFFF-5D7BEC835725

Q40248466-9411C56E-8F8B-48C4-894B-AFD073888A86

Q40248466-9EB8A58F-AB14-42A2-8167-C9FA5DBC38C4

Q40248466-B25C96DD-2960-4266-8A88-550FBF7231F0

Q40248466-BDCFF884-2A19-4198-BA79-2783829B3073

Q40248466-E32A6E6E-D32A-4531-B7C7-6BA7D09525DD

Q40248466-E94370C7-6337-4AD7-B671-9948F41B5DF6

P304

Q40248466-60E0E047-D15C-4DEB-BA8D-E4F5FE6A5DA4

P31

Q40248466-950C8159-65B4-4F34-9E20-53E2A27B8044

P356

Q40248466-01D2CEDD-4404-4400-BCB9-FC7306D8C082

P407

Q40248466-FDF00810-CA29-43A1-BF19-28D4C96D9DE1

P433

Q40248466-D6DD75B9-B7B5-4A0D-AF27-76656831F3B5

P478

Q40248466-EE1E3CBA-A1CC-453E-B270-85D9F3E9FEEA

P577

Q40248466-B51F77A9-A9CF-4E0E-917F-B2711412D5C0

P698

Q40248466-97A4B3DB-53A4-410E-8F4E-4FAC048AB006

P356

0008-5472.CAN-05-4368

P1433

Cancer Research

P1476

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.

@en

P2093

Anh Nguyen

http://www.w3.org/2001/XMLSchema#string

Beth Y Karlan

http://www.w3.org/2001/XMLSchema#string

Bryan T Lin

http://www.w3.org/2001/XMLSchema#string

H Phillip Koeffler

http://www.w3.org/2001/XMLSchema#string

Hsin-Hsiung Tai

http://www.w3.org/2001/XMLSchema#string

Ido Wolf

http://www.w3.org/2001/XMLSchema#string

James O'Kelly

http://www.w3.org/2001/XMLSchema#string

Min Tong

http://www.w3.org/2001/XMLSchema#string

Tamar Rubinek

http://www.w3.org/2001/XMLSchema#string

P304

7818-7823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-4368

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16885386

http://www.w3.org/2001/XMLSchema#string